The following are some of the main factors expected to affect
Swiss stocks on Monday:
ACTELION ATLN.VX
Pharmaceutical company Shire SHP.L is considering a 12
billion pound ($18.32 billion) takeover of Actelion Ltd
ATLN.VX Europe's biggest biotech firm, Britain's Sunday Times
newspaper reported, citing unnamed sources.
For more click on ATLN.VX
UBS UBSG.VX
The Swiss bank appointed Brian Smith, former co-head of
JPMorgan Chase & Co's JPM.N African arm, as the country head
of South Africa and head of investment banking for Sub-Saharan
Africa, according to an internal memo.
For more click on UBSG.VX
COMPANY STATEMENTS CPR-CH
* A spokesman for activist investor Cevian told Swiss paper
Finanz und Wirtschaft that they think ABB's ABBN.VX valuation
does not correctly mirror its worth. ABBN.VX
* Vetropack VET.S said it has signed a purchase agreement
to acquire a glassworks from Bormioli Rocco S.p.A, a company
based in Italy. VET.S
ECONOMY M-CH
SNB weekly sight deposits due at 0700 GMT
(Reporting by Zurich newsroom)
((+41 58 306 7336)(zurich.newsroom@thomsonreuters.com))